Singular Genomics Systems, Inc. (OMIC) Misses Q2 EPS by 824c

Singular Genomics Systems, Inc. (NASDAQ: OMIC) reported Q2 EPS of ($8.57), $8.24 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $700 thousand versus the consensus estimate of $387.5 thousand.

For earnings history and earnings-related data on Singular Genomics Systems, Inc. (OMIC) click here.

You May Also Be Interested In

• Musalem: strong growth and investment influencing bond market - CNBC
• Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance